Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
02/2009
02/26/2009CA2696597A1 Foxm1 peptide and medicinal agent comprising the same
02/26/2009CA2696580A1 Collagen-containing cell carrier
02/26/2009CA2696027A1 Cytotoxicity mediation of cells evidencing surface expression of cd9
02/26/2009CA2695674A1 Metabolomic profiling of prostate cancer
02/26/2009CA2695321A1 Methods for promoting stem cell proliferation and survival
02/26/2009CA2694476A1 Permissive cells and uses thereof
02/25/2009EP2028278A1 RNA sequence-specific mediators of RNA interference
02/25/2009EP2028275A2 Protein glycosylation modification in pichia pastoris
02/25/2009EP2028269A1 Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or Exendin-4 and uses thereof
02/25/2009EP2028268A1 Generation of neuronal cells from pluripotent stem cells
02/25/2009EP2028267A1 Method of producing homologous cellular blood components from hematopoietic progenitor cells
02/25/2009EP2028266A1 Method of producing lymphocytes
02/25/2009EP2028190A1 Compounds and methods for therapy and diagnosis of lung cancer
02/25/2009EP2027874A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment
02/25/2009EP2027869A2 Neuregulin in the treatment of heart diseases
02/25/2009EP2027258A2 Method of differentiating stem cells into cells of the endoderm and pancreatic lineage
02/25/2009EP2027257A1 Bioactive surface for hepatocyte-based applications
02/25/2009EP2027256A2 Animal models of tumour metastasis and toxicity
02/25/2009EP2027255A2 Device and substance for isolating mesenchymal stem cells (msc)
02/25/2009EP2026807A1 Use of parasympatholytic substances to enhance and accelerate stem cell differentiation, related method and compositions
02/25/2009EP1874921A4 Transplantation of differentiated immature adipocytes and biodegradable scaffold for tissue augmentation
02/25/2009EP1776453B1 Isolation of endothelial progenitor cell subsets and methods for their use
02/25/2009EP1516045B1 Use of glutamin-free medium
02/25/2009EP1459758B1 Cofilin for promoting the proliferation and/or differentiation of hematopoietic stem cells and/or hematopoietic precursor cells
02/25/2009EP1442112A4 Optoinjection methods
02/25/2009EP1345495B1 Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics
02/25/2009EP1301795B1 Method of identifying and/or isolating stem cells
02/25/2009EP1240326B1 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify this receptor
02/25/2009EP1142996B1 Monoclonal antibody against apolipoprotein a-i
02/25/2009EP1107665B1 Method of diagnosis of prostate cancer
02/25/2009EP1017721B1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
02/25/2009EP0896058B1 Novel semaphorin z and gene encoding the same
02/25/2009EP0815141B2 Antibodies active against a fusion polypeptide comprising a histidine portion
02/25/2009CN101375161A Antigen-binding proteins targeting staphylococcus aureus ORF0657n
02/25/2009CN101375160A Potentiation of apoptosis by monoclonal antibodies
02/25/2009CN101374960A Method for detecting the presence or absence of a target cell in a sample
02/25/2009CN101374946A Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation
02/25/2009CN101374945A Immunophenotype and immunogenicity of human adipose derived cells
02/25/2009CN101374944A Methods for obtaining immortalized antibody secreting cells
02/25/2009CN101374943A Dissimilar promoters for gene suppression
02/25/2009CN101374942A Method for purifying cardiac myocyte and presumptive cardiac myocyte derived from stem cell and fetus
02/25/2009CN101374941A Improved composition for collecting and preserving placental stem cells and methods of using the composition
02/25/2009CN101374940A Microorganisms comprising enzymes expressed with low gamma-elimination activity
02/25/2009CN101374860A Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of cellular relaxation
02/25/2009CN101374538A Pharmaceutical for promoting functional regeneration of damaged tissue
02/25/2009CN101372707A T lymphocyte for screening and activating dormant infection HIV-1 compound and preparation thereof
02/25/2009CN101372683A Artificial pseudovirus of human hepatitis C, and preparation and application thereof
02/25/2009CN101372682A Construction method of Epinephelus fuscoguttatus fin cell line
02/25/2009CN101371650A Method for inducing dissociate microspore callus of eggplant and regenerating plant strain
02/25/2009CN100464566C Method and equipment of changed digital color image
02/25/2009CN100463967C Testicular carnitine transfer protein and its gene
02/25/2009CN100463963C Freeze preservating method for domestic pig skin tissue
02/25/2009CN100463962C Phenotypic screen of chimeric proteins
02/25/2009CN100463922C Immunoassays for anti-HCV antibodies
02/25/2009CN100463694C Virus coat protein/receptor chimeras and methods of use
02/25/2009CN100463682C Egg white activity extraction extracting and activity measuring technique
02/25/2009CN100463600C Efficient banana in vitro quick-breeding method
02/25/2009CN100463596C Planting process of Chinese medicine pueraria mirifica
02/25/2009CN100463595C Imitating wild planting process of Chinese huperzine serrate
02/24/2009US7495157 Plants and seeds of hybrid corn variety CH434931
02/24/2009US7495156 Plants and seeds of corn variety I059908
02/24/2009US7495155 Plants and seeds of high oil corn variety HOI001
02/24/2009US7495091 Polynucleotides encoding novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
02/24/2009US7495090 An antitumor agent of polynucleotide sequence, a vector, a genetic construct, for encoding a protein
02/24/2009US7495086 TWEAK receptor
02/24/2009US7495082 Antibodies to PRO4349 polypeptides
02/24/2009US7495070 Avian pancreatic polypeptide comprising antigenic specificity for use in treatment and prevention of allergies, infection, inflammation, autoimmune and tumor disorders
02/24/2009US7494982 Modified oligonucleotides for telomerase inhibition
02/24/2009US7494978 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
02/24/2009US7494977 Polypeptides homologous to VEGF and BMP1
02/24/2009US7494812 Transforming lymphocytes with vector comprising gene sequences which code cytolethal distending toxin (cdt), leukotoxins and heat shock protein and generating regulatory cell which can be used to treat and/or prevent transplant rejection, autoimmune and inflammatory diseases; immunotherapy
02/24/2009US7494811 Flowing nutrient solution into, through and out of ground demineralized cells in bioreactor; tissue engineered material
02/24/2009US7494810 Method for accessing microbial diversity
02/24/2009US7494809 Filtration; solvent exchange
02/24/2009US7494808 Methods and interferon deficient substrates for the propagation of viruses
02/24/2009US7494807 Nutrient broth for propagation of hematopoietic stem cells
02/24/2009US7494806 Genetic engineering; gene therapy; packaging cells; long terminal repeats; envelope genes/proteins
02/24/2009US7494805 Expression cassette and vector for transient or stable expression of exogenous molecules
02/24/2009US7494804 Polynucleotide encoding cytokine receptor zcytor17 multimer
02/24/2009US7494800 Which transfer N-acetylgalactosamine to N-acetylglucosamine via beta 1-4 linkage; host cells
02/24/2009US7494788 Entropic bristle domain sequences and their use in recombinant protein production
02/24/2009US7494786 Genetically engineered nuclear inclusion proteinase (NIa) comprising increased stability for obtaining large quantities of purified active proteins that form inclusion bodies in cells; modifying enzyme for premature polypeptides
02/24/2009US7494782 Assay for measuring factor viia-antithrombin complexes
02/24/2009US7494779 Method for producing human antibodies to human CD152 with properties of agonist, antagonist, or inverse agonist
02/24/2009US7494777 Genomic sequence of the 5-lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma
02/24/2009US7494650 Monoclonal antibodies to hepatocyte growth factor
02/24/2009US7494644 contacting a myocardial cells with genetic engineered mammalian cells modified to express a connexin 43 proteins, to establishing electrical coupling between cardiomyocytes and recombinant cells; treatment of cardiac disease or tissue repair
02/24/2009CA2422909C Microstructures for delivering a composition cutaneously to skin
02/24/2009CA2360437C Method of acquiring immunological tolerance
02/24/2009CA2286655C Tissue decellularization
02/24/2009CA2174556C Recombinant p53 adenovirus methods and compositions
02/20/2009CA2597972A1 Method and composition for treating diabetes
02/20/2009CA2597971A1 Method and composition for repairing epithelial and other cells and tissue
02/20/2009CA2597963A1 Method of providing readily available cellular material derived from peripheral blood and a composition thereof
02/20/2009CA2597954A1 Method and composition for repairing heart tissue
02/19/2009WO2009023814A2 Hucbc treatment of amyloid associated disease
02/19/2009WO2009023795A2 Cell-based compositions and method for treating conditions of the nervous system
02/19/2009WO2009023760A1 Novel methods and cell lines
02/19/2009WO2009023566A2 Method of treating autoimmune disease with mesenchymal stem cells
02/19/2009WO2009023562A2 Use of perfusion to enhance production of fed-batch cell culture in bioreactors